Related Experiment Video
Updated: Jul 8, 2026

An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense
Published on: April 17, 2026
Infections caused by Scedosporium spp
Karoll J Cortez1, Emmanuel Roilides, Flavio Quiroz-Telles
1Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
Abstract:
Scedosporium spp. are increasingly recognized as causes of resistant life-threatening infections in immunocompromised patients. Scedosporium spp. also cause a wide spectrum of conditions, including mycetoma, saprobic involvement and colonization of the airways, sinopulmonary infections, extrapulmonary localized infections, and disseminated infections. Invasive scedosporium infections are also associated with central nervous infection following near-drowning accidents. The most common sites of infection are the lungs, sinuses, bones, joints, eyes, and brain. Scedosporium apiospermum and Scedosporium prolificans are the two principal medically important species of this genus. Pseudallescheria boydii, the teleomorph of S. apiospermum, is recognized by the presence of cleistothecia. Recent advances in molecular taxonomy have advanced the understanding of the genus Scedosporium and have demonstrated a wider range of species than heretofore recognized. Studies of the pathogenesis of and immune response to Scedosporium spp. underscore the importance of innate host defenses in protection against these organisms. Microbiological diagnosis of Scedosporium spp. currently depends upon culture and morphological characterization. Molecular tools for clinical microbiological detection of Scedosporium spp. are currently investigational. Infections caused by S. apiospermum and P. boydii in patients and animals may respond to antifungal triazoles. By comparison, infections caused by S. prolificans seldom respond to medical therapy alone. Surgery and reversal of immunosuppression may be the only effective therapeutic options for infections caused by S. prolificans.
Insights
Scedosporium species cause difficult-to-treat infections, especially in immunocompromised individuals. Treatment varies, with Scedosporium prolificans often requiring surgery and immunosuppression reversal.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunocompromised Host
Background:
- Scedosporium species are emerging pathogens causing severe infections in immunocompromised patients.
- These fungi manifest in various conditions, from colonization to disseminated disease, affecting lungs, sinuses, bones, eyes, and brain.
- Key species include Scedosporium apiospermum and Scedosporium prolificans, with Pseudallescheria boydii being the teleomorph of S. apiospermum.
Purpose of the Study:
- To review the spectrum of Scedosporium infections.
- To discuss diagnostic challenges and advances.
- To outline current and potential therapeutic strategies.
Main Methods:
- Literature review of Scedosporium infections.
- Analysis of species identification and taxonomy.
- Summary of clinical manifestations and treatment outcomes.
Main Results:
- Scedosporium infections present diverse clinical syndromes and are often resistant to antifungals.
- S. apiospermum and P. boydii may respond to triazoles, while S. prolificans infections are challenging.
- Innate immunity plays a crucial role in host defense against Scedosporium.
Conclusions:
- Accurate diagnosis and species identification are critical for effective management of Scedosporium infections.
- Treatment strategies must be tailored to the specific species and patient's immune status.
- S. prolificans infections frequently necessitate multimodal approaches including surgery and immunosuppression reversal.
Related Concept Videos
Fungal Phylum Microsporidia
Staphylococcal Skin Infections
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cryptococcal Meningitis
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Candidiasis
